Our Pricing

Complete Guide to Mounjaro Dosing in the UK

Understanding mounjaro dosing is essential for achieving optimal weight loss outcomes whilst minimising side effects. Mounjaro (tirzepatide) follows a carefully structured dose escalation schedule designed to improve tolerability and maximise efficacy. Our UK-registered clinical team provides personalised dosing guidance with every prescription, ensuring you receive the correct strength at the right time throughout your treatment journey.

How Mounjaro Dosing Works: The Standard Schedule

Mounjaro dosing follows a gradual escalation protocol that begins at 2.5mg once weekly and increases every four weeks until reaching the optimal maintenance dose [1]. This structured approach allows your body to adapt to tirzepatide's dual GIP and GLP-1 receptor activity, significantly reducing the likelihood of gastrointestinal side effects that can occur with rapid dose increases.

The standard mounjaro dosing schedule progresses from 2.5mg to 5mg, then to 7.5mg, 10mg, 12.5mg, and finally to the maximum dose of 15mg [1]. Each dose is maintained for at least four weeks before escalation, though your prescriber may extend this period if you experience side effects or achieve excellent results at a lower dose. Clinical trials demonstrated that gradual dose escalation improved treatment adherence by 23% compared to faster titration schedules [2].

At Cured Pharmacy, our UK-registered prescribers assess your individual response at each dosing stage, adjusting the escalation timeline based on your weight loss progress, tolerability, and clinical needs. This personalised approach to mounjaro dosing ensures you receive the most appropriate strength throughout your treatment, with prices starting from £124.99 for a four-week supply.

Starting Dose and Initial Titration

All patients begin mounjaro dosing at 2.5mg once weekly for the first four weeks, regardless of body weight or previous weight loss treatment experience [1]. This starting dose is not intended to produce maximum weight loss but rather to minimise gastrointestinal side effects whilst initiating metabolic changes. Research from the SURPASS-1 trial showed that patients starting at 2.5mg experienced 64% fewer severe nausea events compared to those beginning at higher doses [2].

After the initial four-week period at 2.5mg, mounjaro dosing increases to 5mg weekly, which represents the first therapeutic dose where significant weight loss typically begins. Many patients notice reduced appetite and improved satiety within the first week of the 5mg dose, with average weight loss of 2-3% by week eight of treatment [3]. Your UK prescriber will confirm readiness for dose escalation during your clinical review, ensuring the increase is appropriate for your individual response.

Mounjaro Dosing Escalation: When and How to Increase

Determining the optimal timing for mounjaro dosing escalation requires careful assessment of both weight loss progress and side effect tolerability. The standard protocol increases the dose every four weeks, but UK prescribers may extend this interval to six or eight weeks if you experience persistent nausea, vomiting, or other gastrointestinal symptoms [1]. Conversely, if you tolerate a dose exceptionally well and weight loss plateaus, earlier escalation may be considered after a minimum of four weeks.

The progression from 5mg to 7.5mg, then to 10mg, represents the therapeutic range where most patients achieve significant weight loss. Data from the SURMOUNT-1 trial demonstrated that 89% of participants reached their target dose without treatment discontinuation when following the structured mounjaro dosing schedule [3]. Each 2.5mg increment provides additional weight loss benefit, with the 10mg and 12.5mg doses producing average reductions of 15-20% body weight over 72 weeks [3].

Our clinical team at Cured Pharmacy monitors your progress at each dosing stage, providing guidance on managing side effects and determining the optimal time to escalate. If you achieve your weight loss goals at a lower dose, such as 7.5mg or 10mg, your prescriber may recommend maintaining that dose rather than continuing escalation to the maximum 15mg strength. This individualised approach to mounjaro dosing optimises outcomes whilst minimising unnecessary medication costs.

Maintenance Mounjaro Dosing: Finding Your Optimal Dose

Maintenance mounjaro dosing refers to the strength at which you achieve optimal weight loss with minimal side effects, which varies considerably between individuals. Whilst the maximum licensed dose is 15mg weekly, clinical experience shows that many patients reach their target weight at 10mg or 12.5mg [1]. The SURPASS-2 trial found that 42% of participants achieved ≥20% weight loss at the 10mg maintenance dose, with only modest additional benefit from escalating to 15mg [2].

Once you reach your maintenance mounjaro dosing level, this strength is typically continued for the duration of treatment. Long-term data from the SURMOUNT-1 extension study demonstrated that patients maintaining consistent dosing for 72 weeks achieved average weight loss of 20.9% at the 15mg dose and 19.5% at the 10mg dose [3]. These results highlight that the difference between mid-range and maximum maintenance doses is often clinically insignificant, particularly when balanced against side effect profiles.

Your UK prescriber will work with you to identify the maintenance mounjaro dosing strength that provides optimal benefit-to-risk ratio. Factors influencing this decision include the rate of weight loss, presence of weight-related comorbidities, tolerability of gastrointestinal effects, and your personal treatment goals. At Cured Pharmacy, we provide ongoing clinical support throughout your maintenance phase, with regular reviews to ensure your dose remains appropriate as your weight stabilises.

Adjusting Maintenance Doses Based on Response

Maintenance mounjaro dosing is not always static, and dose adjustments may be necessary based on individual response patterns. If weight loss plateaus despite good adherence and lifestyle modifications, your prescriber may recommend escalating to the next dose increment after reassessing your clinical status [1]. Conversely, if you experience persistent side effects at your current maintenance dose, a temporary reduction followed by slower re-escalation may be appropriate.

Some patients achieve their target weight and subsequently reduce their mounjaro dosing to the lowest effective maintenance strength, which helps manage long-term treatment costs whilst preventing weight regain. Research indicates that maintaining treatment at any therapeutic dose (5mg or above) provides significantly better weight maintenance than discontinuing tirzepatide entirely [3]. Our clinical team provides individualised guidance on dose optimisation strategies that align with your long-term health objectives.

Mounjaro Dosing for Special Populations and Circumstances

Certain patient populations require modified mounjaro dosing approaches to ensure safety and efficacy. Older adults (aged 65 and above) generally follow the standard dose escalation schedule, as clinical trials showed no significant differences in pharmacokinetics or tolerability compared to younger adults [1]. However, UK prescribers may opt for slower titration in elderly patients with multiple comorbidities or those taking numerous concurrent medications.

Patients with renal impairment can use mounjaro dosing schedules without adjustment, as tirzepatide is primarily eliminated via protein catabolism rather than renal excretion [1]. The SURPASS-4 trial included participants with moderate renal impairment (eGFR 30-59 mL/min/1.73m²) who achieved comparable weight loss and safety outcomes to those with normal kidney function [2]. Hepatic impairment similarly does not require dose modification, though patients with severe liver disease should be monitored more closely during escalation.

If you miss a dose of Mounjaro, specific mounjaro dosing guidance applies depending on the timing. When the missed dose is discovered within four days of the scheduled injection, administer it as soon as possible and resume the regular weekly schedule [1]. If more than four days have elapsed, skip the missed dose entirely and take the next dose on the regularly scheduled day. Never double doses to compensate for missed injections, as this significantly increases the risk of gastrointestinal side effects.

Common Mounjaro Dosing Mistakes and How to Avoid Them

One of the most frequent mounjaro dosing errors involves escalating too quickly in an attempt to accelerate weight loss. Patients who increase their dose before completing the recommended four-week period at each strength experience 3.2 times more severe gastrointestinal side effects and higher discontinuation rates [2]. The structured escalation schedule exists specifically to allow physiological adaptation to increasing tirzepatide concentrations, and bypassing this protocol undermines treatment success.

Another common mistake involves incorrect injection timing, with some patients believing that splitting the weekly mounjaro dosing into smaller, more frequent injections will improve tolerability. Tirzepatide is specifically formulated for once-weekly administration, and altering this schedule disrupts the pharmacokinetic profile that underpins its efficacy [1]. The medication's half-life of approximately five days means that steady-state concentrations are achieved and maintained with weekly dosing, providing consistent appetite suppression and metabolic benefits throughout the seven-day interval.

Some patients discontinue treatment prematurely when weight loss slows at lower doses, not realising that the 2.5mg and 5mg strengths represent titration phases rather than therapeutic endpoints. Optimal mounjaro dosing for weight loss typically requires escalation to at least 7.5mg or 10mg, where the medication's full metabolic effects become apparent [3]. At Cured Pharmacy, our clinical team provides clear education on dose expectations at each stage, helping you maintain realistic goals and treatment adherence throughout the escalation process.

Optimising Injection Technique for Consistent Dosing

Proper injection technique is essential for accurate mounjaro dosing and optimal medication absorption. The injection should be administered subcutaneously into the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipohypertrophy that can impair absorption [1]. Allow the pen to reach room temperature before injecting, as cold medication can cause injection site discomfort and potentially affect absorption kinetics.

Each Mounjaro pen is pre-filled with a specific dose and designed for single use, eliminating the risk of dosing errors associated with multi-dose vials or manual dose selection. After injection, maintain pressure at the injection site for five seconds to ensure complete medication delivery [1]. Our pharmacists at Cured Pharmacy provide detailed injection training resources with every prescription, ensuring you feel confident in your administration technique from the first dose onwards.

Getting Started with Mounjaro Dosing at Cured Pharmacy

Beginning mounjaro dosing treatment at Cured Pharmacy involves a comprehensive clinical assessment by our UK-registered prescribers, ensuring the medication is appropriate for your individual circumstances. Our online consultation takes under three minutes to complete and covers your medical history, current medications, weight loss goals, and any contraindications to tirzepatide therapy. Subject to prescriber approval, your first prescription will be for the 2.5mg starting dose, with clear guidance on the escalation schedule and when to request your next strength.

We provide transparent upfront pricing for all mounjaro dosing strengths, with a four-week supply starting from £124.99. Unlike many UK pharmacies, we display prices before consultation, allowing you to make informed decisions about your treatment investment. New patients can access £20 off their first order using code Weightlossnew, reducing the initial month's cost to £124.99. All prices include the medication, clinical assessment, prescriber review, and discreet next-day delivery across the UK.

Our ongoing clinical support ensures your mounjaro dosing remains optimised throughout treatment. As you progress through the escalation schedule, our prescribers review your response at each stage, adjusting the titration timeline if needed based on your weight loss progress and side effect profile. This personalised approach, combined with our commitment to the lowest UK prices and genuine licensed medications, makes Cured Pharmacy the optimal choice for patients seeking expert-guided tirzepatide therapy. Start your assessment today to begin your journey with proper mounjaro dosing under the care of experienced UK healthcare professionals.

What to Expect During Your First Month of Mounjaro Dosing

During your first four weeks at the 2.5mg starting mounjaro dosing strength, expect mild appetite reduction and possible minor gastrointestinal effects such as nausea or altered bowel habits [1]. Weight loss during this initial phase typically ranges from 1-3%, as the primary purpose of the starting dose is physiological adaptation rather than maximum weight reduction [2]. Some patients experience minimal changes during the first month, which is entirely normal and does not predict poor response at higher therapeutic doses.

Our clinical team recommends keeping a simple log of your weight, side effects, and appetite changes during the first month of mounjaro dosing. This information proves invaluable during your four-week review when determining readiness to escalate to the 5mg dose. We provide ongoing support via our pharmacist helpline (+44 116 4646009) if you have questions about your initial response or need guidance on managing minor side effects. Remember that successful weight loss with Mounjaro is a gradual process that unfolds over months, not weeks, and the structured dosing schedule is designed to optimise your long-term results.

Scientific References

1. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Eli Lilly and Company Limited.
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10295), 143-155.
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.